Results

Results: * UOB: 3Q12 reported profit held up well at $705m, -1% qoq, +35% yoy. But analysts note underlying result quality short of expectations, as net interest income and fee revenue disappointed, but was made up for by trading and other income. * ST Engg: 3Q12 results broadly in line. Revenue at $1.54b, +11% yoy, -2% qoq; net profit at $146.4m, +9.5% yoy, +22% qoq. Analysts note healthy growth across all divisions. * OUE: 3Q12 results broadly in line. Net profit at $23.8m, +21% yoy, +5% qoq. Key focus will continue to be on M&A, as OUE will clarify its intentions on whether to make an offer for FNN by no later than 15 Nov ’12. * Biosensors: 2QFY13 results below expectations, with revenue at US$66.8m, +28% yoy, -8% qoq, and net profit at US$28.2m, +23% yoy, -14% qoq, mainly due to weaker licensing revenue from Terumo. Nevertheless, analysts see positives in stronger gross margins and more favorable revised licensing agreements with Terumo. Mgt confident to regain market share in Japan. * Jardine Matheson/ Jardine Strategic: Interim Management Statement for period from 1 Jul – 6 Nov ’12, in line with Credit Suisse expectations. * Ho Bee: 3Q12 results largely in line. Net profit at $31.5m, -3% yoy, -57% qoq, revenue at $59.1m, +5.6%, with contribution coming mainly from Trilight and Parvis. * BreadTalk: 3Q12 revenue at $117m +22% yoy on same-store growth at +9.2% yoy and new stores that opened in the quarter. Net profit at $3.39m, +8% yoy. * Aspial: 9M12 revenue at $319.7m, +3% yoy, net profit at $35.9m, +2% yoy.